First Interim Safety Analysis of a Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated by Autologous Hematopoietic Stem Cell Transplant,

d'Amore, Francesco ; da Silva, Maria Gomes ; Leppa, Sirpa

; Relander, Thomas ; Pezzutto, Antonio ; Lauritzsen, Grete F. ; Weidmann, Eckhart ; Van Gelder, Michel ; Merup, Mats ; Hagberg, Hans ; Fagerli, Unn-Merete ; Brown, Peter de Nully ; Hansen, Per Boye ; Mariz, Jose Mario ; Jankovska, Milada ; Walewski, Jan ; Doorduijn, Jeanette ; Van Hoof, Achiel ; Christiansen, Ilse ; Jyrkkiö, Sirkku ; Kluin-Nelemans, J.C. ; van Marwijk Kooy, Marinus ; Fijnheer, Rob ; Stevens, Wendy ; Zijlstra, Josee ; Böhmer, L. ; Lugtenburg, P.J. ; Grube, Matthias ; Prochazka, Vit ; Salek, David ; Greil, Richard

; Trümper, Lorenz ; Wulf, Gerald ; Altmann, Bettina ; Ziepert, Marita ; Loeffler, Markus ; Jantunen, Esa ; Hopfinger, Georg ; Neste, Eric Van den ; Toldbod, Helle

Alternative links to fulltext:DOI Publisher